Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Pacific Biosciences director Christopher M. Smith resigns from board effective immediately

Neutral Impact 2 of 5 leadership Written later

Pacific Biosciences of California, Inc. disclosed that director Christopher M. Smith notified the company on July 8, 2026, that he is resigning from its board effective immediately. The company said it is not aware of any disagreement with Mr. Smith over its operations, policies or practices that led to the resignation, so the filing reports a board change without a stated cause.

Key points

  • Director Christopher M. Smith resigned from the board, effective immediately.
  • Notice of resignation was given to the company on July 8, 2026.
  • The company states it is not aware of any disagreement that led to the resignation.
  • The 8-K was signed by General Counsel Brett Atkins on July 9, 2026.

The filing

CompanyPACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Form8-K, current report
Filed with the SECJul 9, 2026, 4:32 PM ET
Accession number0001299130-26-000111

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 09, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.